Core Insights - The World Intellectual Property Organization (WIPO) has reported that China has successfully risen to the top ten in the global innovation index, highlighting significant progress in technology research and innovation ecosystem development [1] - The upcoming 20th Central Committee meeting is expected to focus on innovation as a key direction for the 14th Five-Year Plan, increasing market attention on companies' technological innovations and strategies [1] Group 1: Company Performance - Fosun International has demonstrated steady revenue and profit growth driven by its core capabilities in innovation and globalization, with a positive outlook from multiple securities firms [1][2] - The company has received "buy" or "hold" ratings from various institutions, with target prices ranging from 6.5 to 7.5 HKD [1] Group 2: Innovation and Drug Development - Fosun has made significant advancements in its health sector, with innovative drugs like HLX43, a PD-L1 antibody-drug conjugate, undergoing clinical trials in multiple countries [2] - The company has also achieved breakthroughs with its self-developed targeted drug, Fumainin, which has been approved for rare disease indications, filling treatment gaps in oncology [2] Group 3: Globalization Strategy - Fosun has built a global research, registration, and marketing capability over the past decade, with its biopharmaceutical products reaching nearly 60 countries and benefiting over 850,000 patients [3] - The company has established a leading platform for small molecule innovation and has completed over 800 regulatory applications globally, with more than 600 approvals [3] Group 4: AI and Digital Transformation - Fosun is leveraging AI across various business sectors, enhancing customer experiences in tourism and improving operational efficiency in insurance [4] - The company has partnered with Alibaba Cloud to develop an AI-driven tourism assistant, significantly enhancing customer service capabilities [4] Group 5: Financial Strength and Capital Operations - Fosun has shown robust financing capabilities and an optimized financial structure, with a recent syndicate loan agreement reaching a record high of 9.1 billion USD equivalent [5] - The company is expected to continue optimizing its asset structure following recent interest rate cuts by the Federal Reserve, maintaining financial stability [5]

Core Insights - The tourism industry is transitioning from "sightseeing" to "vacationing," emphasizing the need for high-quality tourism products to meet personalized and high-quality consumer demands [2] - The "14th Five-Year Plan" period is crucial for China to advance from a tourism power to a tourism strong nation, focusing on enhancing the quality of tourism offerings [2] - Fosun Tourism Group aims to create world-class vacation products and align with national tourism development goals [2] Company Overview - Fosun Tourism Group operates nearly 70 resorts and hotels across over 40 countries and regions, generating annual revenue exceeding 19 billion yuan and hosting over 8.6 million guests each year [3] - The company has developed four main product lines: Club Med Global, Club Med China, Super Vacation Zones, and Super Cultural Tourism Malls [3]

Core Viewpoint - China Guo Xin Service Holding Limited is preparing for an IPO on the Hong Kong Stock Exchange, aiming to leverage its established brand and reputation in property management and agency services in Guangdong and Hunan provinces [5][6]. Company Overview - Established in 2006, China Guo Xin Service Group is a comprehensive property management and agency service provider, with a significant presence in Guangdong and Hunan provinces [5]. - The company expanded its geographical reach by acquiring Hunan Zhida Property Management in January 2024 [5]. - As of June 30, 2025, the company managed a total contracted area of 5.9 million square meters across 42 property projects, including 24 residential and 18 non-residential properties [5]. Market Position - China Guo Xin Service Group ranks as the fourth largest market participant in the Greater Bay Area property management and agency services market, holding a market share of 0.08% [5]. - The company is also among the top 50 property management service providers in Hunan province, with a market share of 0.06% [5]. Financial Performance - The company reported revenues of RMB 88.127 million, RMB 115.358 million, RMB 196.005 million, and RMB 89.135 million for the years 2022, 2023, 2024, and the first half of 2025, respectively [11]. - Net profits for the same periods were RMB 20.184 million, RMB 28.077 million, RMB 39.041 million, and RMB 12.202 million [10][11]. - Revenue from properties developed by the controlling shareholder accounted for 100.0%, 99.4%, 73.8%, 70.4%, and 68.7% of total revenue from 2022 to the first half of 2025 [6]. Shareholder Structure - The pre-IPO shareholder structure indicates that Mr. Liang Zanwen, through Guo Xin Holdings, holds 100% of the shares [11]. Management Team - The board of directors consists of 7 members, including 4 executive directors and 3 independent non-executive directors [9].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | 狀態: | 新提交 | | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | 公司名稱: | 復星國際有限公司 | | | | 呈交日期: | 2025年10月3日 | | | | I. 法定/註冊股本變動 不適用 | | | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | | 股份類別 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00656 | 說明 | | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | | 已發行股份總數 | | | 上月底結存 | | | 8,166,558,124 | | | 0 | | 8,166,558, ...

Transaction Overview - The jewelry fashion group plans to introduce investors for financing, with Bank of China Asset increasing capital by RMB 400 million, acquiring 3.5596% equity in the target company [1] - After the transaction, Fosun International will still indirectly hold 91.03% equity through Yuyuan Shares, maintaining control [1] Valuation Basis - According to an independent valuation report, the net asset valuation of the jewelry fashion group is RMB 9.016 billion, with a pre-investment valuation determined based on a projected net profit of RMB 241 million for the second half of 2024 [2] - The investment arrangement includes a buyback option for external investors after 60 months, with the buyback price calculated at an annualized return of 8% [2] - Institutional investors have a transfer option during a 3-year investment period, which can be extended by 2 years [2] Financial Performance - The jewelry fashion group is projected to have a revenue of RMB 29.996 billion and a net profit of RMB 714 million in 2024; for the first half of 2025, revenue is expected to be RMB 12.899 billion with a net profit of RMB 290 million [3] Significance of Listing Rules - The transaction constitutes a major transaction that has received written approval from the controlling shareholder, Fosun Holdings, and does not require a shareholders' meeting [4] - The funds raised will be used to repay qualified financial institution debts [4] External Investors - A total of 36 investors contributed RMB 770 million through Heze Zhuying [5] - Bank of China Asset increased capital by RMB 600 million, acquiring 5.4059% equity [5] - The total financing scale reached RMB 1.98 billion [5]

Adopted on [▪], 2025 | 1. | DEFINITIONS AND INTERPRETATION | 1 | | --- | --- | --- | | 2. | PURPOSES OF THE SCHEME | 5 | | 3. | CONDITIONS | 6 | | 4. | DURATION | 6 | | 5. | ADMINISTRATION | 6 | | 6. | ELIGIBLE EMPLOYEES | 7 | | 7. | CONDITIONS AND TIMING OF GRANT | 8 | | 8. | GRANT INSTRUMENT AND NOTIFICATION OF GRANT | 9 | | 9. | SOURCES OF RESTRICTED SHARES | 10 | | 10. | PROPOSED ALLOCATION UNDER THE FIRST GRANT | 12 | | 11. VESTING | PERIOD AND VESTING CONDITIONS | 13 | | 12. | VESTING OF RSUS | 17 | | ...

復 星 國 際 有 限 公 司 Dear Non-registered Holder (Note) , 25 September 2025 Fosun International Limited (the "Company") Notice of Publication of (i) Interim Report 2025; (ii) Circular dated 25 September 2025 in relation to Major Transaction in relation to Deemed Disposal of Equity Interest in Jewelry Fashion Group; (iii) Circular dated 25 September 2025 in relation to Proposed Adoption of the 2025 H Share RSU Scheme of Fosun Pharma and Notice of Extraordinary General Meeting; and (iv) Proxy Form (collectively the ...

FOSUN INTERNATIONAL LIMITED （在香港註冊成立之有限公司） (Incorporated in Hong Kong with limited liability) (Stock Code / 股份代號: 00656) N OT IF IC ATI ON LET TE R 通 知 信 函 25 September 2025 Dear Registered Holder, Fosun International Limited (the "Company") Notice of Publication of (i) Interim Report 2025; (ii) Circular dated 25 September 2025 in relation to Major Transaction in r elation to Deemed Disposal of Equity Interest in Jewelry Fashion Group; (iii) Circular dated 25 September 2025 in relation to Proposed Adoption ...

為本人╱吾等之代表，出席本公司於2025年10月23日（ 星期四 ）上午十時正假座中國上海市黃浦區中山東二路600號外灘金 融中心S1幢39樓舉行之股東特別大會（「大會」），藉以考慮並酌情批准大會通告所載決議案，並於大會（ 及其任何續會 ）以 本人╱吾等名義，就該決議案按下文所載指示代表本人╱吾等投票。除文義另有所指外，此處所使用之詞彙與本公司日 期為2025年9月25日通函所使用者具有相同涵義。 地址為 為復星國際有限公司（「本公司」）股本中已發行股份 （ 附 註 2 ） 股之登記持有人， 茲委任 （ 附 註 3 ） 大會主席，或 地址為 或（ 如其未克出席） 地址為 於2025年10月23日（星期四）召開之股東特別大會適用之代表委任表格 本代表委任表格所涉及的股份 本人╱吾等 （ 附 註 1 ） | （ | 附 | 註 | ） | （ | 附 | 註 | ） | 普通決議案 | 贊成 | 反對 | 4 | 4 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 受限於並以復星醫藥股東於復星醫 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本通告全部或任何部分內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 除文 義另 有所 指外 ，本 通告 所用 詞彙 與復 星國 際有 限公 司（「 本公 司」）日期 為2025 年9 月 25 日的通函（「通函」，內容有關建議採納復星醫藥2025年H股受限制股份單位計劃 ）所界定者 具有相同涵義。本通告所載決議案的詳情載於通函內。 股東特別大會通告 茲通告本公司謹訂於2025年10月23日（ 星期四 ）上午十時正假座中國上海市黃浦區中山東二 路600號外灘金融中心S1幢39樓舉行股東特別大會（「股東特別大會」）討論下列事項： 1. 作為特別事項，考慮並酌情通過（ 無論有否修訂）下列決議案為普通決議案： 「動議： 受限於並以復星醫藥股東於復星醫藥臨時股東會通過批准採納復星醫藥2025年H股受限 制股份單位計劃的普通決議案為條件，批准採納2025年H股受限制股份單位計劃（ 其註 有「A」字樣之副本已提呈大會，並由大會主席簽署以資識別 ），以及授權本公司任何董 事及╱ 或其 ...